Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T05:44:05.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Successful treatment of disseminated adenovirus infection with cidofovir and intravenous immunoglobulin in an infant following heart transplant

Part of: Infectious

Published online by Cambridge University Press:  25 April 2018

Ryan M. Serrano ,
Robert K. Darragh  and
John J. Parent
Ryan M. Serrano*
Affiliation:
Pediatric Cardiology, Riley Hospital for Children, Indianapolis, IN, USA
Robert K. Darragh
Affiliation:
Pediatric Cardiology, Riley Hospital for Children, Indianapolis, IN, USA
John J. Parent
Affiliation:
Pediatric Cardiology, Riley Hospital for Children, Indianapolis, IN, USA
*
Author for correspondence: R. M. Serrano, Pediatric Cardiology, 705 Riley Hospital Drive, RR 127, Indianapolis, IN 46202, USA. Tel: +317 274 8906; Fax: +317 274 4022; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

For most patients, adenoviruses cause few acute health concerns and are often self-limiting. Patients who are immunocompromised or immunosuppressed, however, are at risk for disseminated adenovirus and suffer high morbidity and mortality, without well-defined treatment options. We report the case of a 9-month-old boy who was successfully treated for disseminated adenovirus infection with intravenous immunoglobulin and cidofovir 3 months post heart transplant, tailored to serum adenoviral load and clinical response. We emphasise the importance of early identification, monitoring, and a potentially novel treatment in the paediatric cardiac transplant population with disseminated adenovirus infection.

Keywords

Cardiac transplantationadenovirusIVIG
Type
Brief Report
Information
Cardiology in the Young , Volume 28 , Issue 6 , June 2018 , pp. 888 - 889
Check for updates
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ison, M. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331–339.CrossRefGoogle ScholarPubMed
2. Munoz, F, Piedra, P, Demmler, G. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 1998; 27: 1194–1200.CrossRefGoogle ScholarPubMed
3. Yusuf, U, Hale, G, Gu, Z, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81: 1398–1404.CrossRefGoogle ScholarPubMed
4. Carter, B, Karpen, S, Quiros-Tejeira, R, et al. Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation 2002; 74: 1050–1052.CrossRefGoogle Scholar